I wrote this very brief outline of the video for someone, and i thought it might be of interest to others, so i'll post it here.
I've only watched the video once, and the details weren't always very clear, so i may have got the odd detail wrong... corrections are welcome...
There wasn't a great deal new in the video, but there were some interesting snippets about his ongoing research. Alan highlighted two or three papers that have found the same autoantibodies in CFS patients (autoantibodies to beta adrenergic receptors), and he seems quite interested in doing research in relation to these autoantibodies. He also mentioned a study that he's doing whereby he has sent blinded blood samples to another researcher to detect autoantibodies in CFS patients. This could be interesting if it gives positive results, but he didn't give us any details. And then, finally, he discussed his latest gene expression research that looked at the gene expresssion of CFS+fibro (comorbid - not CFS by itself) and fibro patients after exercise when taking placebo or pregabalin (he's also interested in gabapentin). For the responders to the drug, he demonstrated that the drug approximately normalised the genetic response to exercise, for a small selection of genes. (Possibly just two or three genes of interest.) i.e. the drugs correct the gene expression response to exercise, and improve symptoms. This was quite interesting because it shows that the response to treatment is accompanied with normalisation of some biomarkers. For the non-responders to the drug the gene expression was out of whack. I'm not sure where he's going with this research, or what benefits there may be for patients, but it's quite interesting nonetheless.